Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
Clinical trial NCT04009824 · COMPLETED
Trial details
- NCT number
- NCT04009824
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2020-03-03
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.